The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 1 of 4
Back to Result List

Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration

Please always quote using this URN: urn:nbn:de:bvb:20-opus-222882
  • The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissueThe incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Marietta Herrmann, Solvig Diederichs, Svitlana Melnik, Jana Riegger, Drenka Trivanović, Shushan Li, Zsuzsa Jenei-Lanzl, Rolf E. Brenner, Markus Huber-Lang, Frank Zaucke, Frank A. Schildberg, Susanne Grässel
URN:urn:nbn:de:bvb:20-opus-222882
Document Type:Journal article
Faculties:Medizinische Fakultät / Lehrstuhl für Orthopädie
Language:English
Parent Title (English):Frontiers in Bioengineering and Biotechnology
ISSN:2296-4185
Year of Completion:2021
Volume:8
Article Number:624096
Source:Frontiers in Bioengineering and Biotechnology 2021, 8:624096. doi: 10.3389/fbioe.2020.624096
DOI:https://doi.org/10.3389/fbioe.2020.624096
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:MSC; cell-free therapeutics; exosomes; extracellular vesicles; iMP; musculoskeletal diseases
Release Date:2021/03/15
Date of first Publication:2021/01/20
Open-Access-Publikationsfonds / Förderzeitraum 2020
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International